VaDDC
  • About
    • Join VaDDC
    • Affiliated Organizations
  • Leadership
    • Executive committee members
  • Events
    • VaDDRx 2022: Cardiovascular, Pulmonary, and Metabolic Disease
    • VaDDRx: CoronaVirus Therapeutics, Present and Future 2021
    • VaDDRx: Emerging Targets, Technologies and Therapeutics for Cancer and Neuroscience 2019
    • VirginiaDrugDiscoveryRx 2018
    • VirginiaCancerRx 2017
    • VirginiaBrainRx 2016
  • News
  • Partnerships
    • Industry Initiatives
    • Featured Collaborations
    • Become a Sponsor
Select Page
KeViRx-UVA-ODU Collaborative SBIR Grant funded

KeViRx-UVA-ODU Collaborative SBIR Grant funded

by Discovery | Oct 1, 2021 | Uncategorized

KeViRx is an early stage drug discovery company spun out of the UVA Department of Pharmacology by Elizabeth Sharlow and John Lazo and is located in Charlottesville. KeViRx was just awarded its second National Institutes of Health R43 Phase 1 Small Business Innovation...

Recent Posts

  • Executive Committee Chair Paul Carlier Chosen as Director of UIChicago’s UICentre
  • Exec. Committee Member Beth Sharlow on UVA’s Fiske Drug Discovery Lab
  • KeViRx Selected as Part of BLUE KNIGHT™ Collaboration for Global Health Preparedness
  • Desai Grant on Factor XIa Inhibitors Funded
  • KeViRx-UVA-ODU Collaborative SBIR Grant funded

Archives

  • July 2022
  • March 2022
  • February 2022
  • January 2022
  • October 2021
  • September 2021
  • August 2021
  • June 2021
  • June 2020
  • May 2020
  • July 2019
  • March 2019
  • December 2018
  • November 2018
  • September 2018
  • September 2017
  • June 2017
  • May 2017
  • February 2017
  • December 2016
  • November 2016
  • September 2016
  • July 2016
  • April 2015
© 2016 Virginia Drug Discovery Consortium | website by michaelclapp.info